Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001714899-24-000218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-12 | 2024-11-07 | DNLI | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $29.91 | -15.6K | 178.1K | -8% | -$465.3K |
| D | 2024-11-12 | 2024-11-07 | DNLI | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +15.6K | 193.6K | +9% | +$82.1K |
| D | 2024-11-12 | 2024-11-07 | DNLI | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.00 | -15.6K | 53.4K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | S | D | 12,333 | $29.68 | 181,291 | D | — | — | (F3) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.21 to $30.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 118,810 Unvested RSUs. |
| 2 | Common | Common Stock | 2024-11-07 | S | D | 2,925 | $30.72 | 178,366 | D | — | — | (F4) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.21 to $31.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 118,810 Unvested RSUs. |
| 3 | Common | Common Stock | 2024-11-07 | S | D | 300 | $31.29 | 178,066 | D | — | — | (F5) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.27 to $31.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 118,810 Unvested RSUs. |
| 4 | Common | Common Stock | 2024-11-07 | M | A | 15,558 | $5.28 | 193,624 | D | — | — | (F1) Includes 118,810 Unvested RSUs. |
| 5 | Derivative | Stock Option (right to buy) | 2024-11-07 | M | D | 15,558 | $0.00 | 53,379 | D | $5.28 · — to 2027-03-07 | 15,558 Common Stock | (F7) 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. |